MARLE GROUP acquired by IK PARTNERS

Marle Group has acquired Nowak from a consortium of private equity investors led by Siparex Midcap, alongside Bpifrance, Unexo, and the management team. This acquisition strengthens Marle's vertical integration by adding specialized casting capabilities. The deal follows a successful transformation period under Siparex (2018-2023), where Nowak shifted its focus toward the medical sector and acquired Belmonte. The transaction was financed via a unitranche debt facility provided by Capza.

Dentressangle has entered into exclusive negotiations to acquire a majority stake in Marle Group from IK Investment Partners on a preemptive basis, successfully securing the asset outside of a traditional, highly competitive auction process. Marle Group is a premier European leader and a dominant global contract manufacturing organization (CMO) specializing in high-precision orthopedic implants and surgical instruments. The company commands high barriers to entry rooted in its fully vertically integrated manufacturing process (foundry, machining, specialized coating, sterile packaging) and strict international regulatory compliance (FDA, CE mark). Dentressangle’s investment thesis centers on deploying patient, long-term family capital to drive an aggressive international "buy-and-build" strategy (specifically targeting capacity expansion in North America) while diversifying Marle’s capabilities into adjacent high-margin medical device manufacturing niches.

The Carlyle Group has acquired an 80% majority stake in Marle S.A. The company's President, Bernard Marle, along with his family, has reinvested to retain a 20% stake. This Primary LBO is designed to support the company's growth in a market expanding at 8% annually. The transaction structure includes a senior debt package co-arranged by CIC Est and LCL, as well as a vendor loan (credit-vendeur). Carlyle aims to professionalize the company and accelerate its international expansion.